share_log

NRX PHARMACEUTICALS INC C/WTS 24/05/2026 (TO PUR COM) | 8-K: NRx Pharmaceuticals (Nasdaq:NRXP) Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update

SEC announcement ·  Apr 2 06:09
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more